Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Given Average Rating of "Moderate Buy" by Brokerages

Key Points

• Sabra Healthcare REIT holds a “Moderate Buy” consensus rating: Seven of 13 analysts recommend buying the stock, while six rate it a hold. The average 12-month price target is $22.27, above the reported $20.61 share price.
• Institutional ownership is substantial and investors recently increased positions: Institutional investors own 99.40% of SBRA, with several firms—including First Trust Advisors and Cerity Partners—boosting their stakes.
• The company announced a quarterly dividend of $0.30 per share: The annualized dividend is $1.20, representing a 5.8% yield, though the payout ratio is high at 461.54%. Sabra’s latest quarterly revenue rose 24.7% year over year but earnings missed analyst expectations.

Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Get Free Report) have been given a consensus rating of "Moderate Buy" by the thirteen brokerages that are currently covering the firm, MarketBeat Ratings reports. Six investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $22.2727.

Several equities analysts have commented on the stock. Weiss Ratings lowered shares of Sabra Healthcare REIT from a "buy (b)" rating to a "hold (c+)" rating in a report on Tuesday, August 4th. Citizens Jmp upped their target price on Sabra Healthcare REIT from $23.00 to $25.00 and gave the stock a "market outperform" rating in a research note on Wednesday, July 22nd. Barclays began coverage on Sabra Healthcare REIT in a report on Tuesday, July 7th. They issued an "overweight" rating and a $21.00 target price on the stock. Wall Street Zen upgraded Sabra Healthcare REIT from a "sell" rating to a "hold" rating in a research note on Sunday, June 28th. Finally, Wells Fargo & Company boosted their price target on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock an "overweight" rating in a report on Monday, June 1st.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in SBRA. Focus Partners Wealth boosted its stake in shares of Sabra Healthcare REIT by 11.4% in the 1st quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust's stock valued at $404,000 after purchasing an additional 2,375 shares in the last quarter. EverSource Wealth Advisors LLC grew its holdings in shares of Sabra Healthcare REIT by 150.7% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust's stock valued at $47,000 after purchasing an additional 1,536 shares during the last quarter. First Trust Advisors LP increased its position in Sabra Healthcare REIT by 27.2% during the 2nd quarter. First Trust Advisors LP now owns 368,383 shares of the real estate investment trust's stock worth $6,793,000 after purchasing an additional 78,709 shares in the last quarter. Cerity Partners LLC increased its position in Sabra Healthcare REIT by 73.0% during the 2nd quarter. Cerity Partners LLC now owns 18,686 shares of the real estate investment trust's stock worth $345,000 after purchasing an additional 7,885 shares in the last quarter. Finally, Daiwa Securities Group Inc. increased its position in Sabra Healthcare REIT by 3.1% during the 2nd quarter. Daiwa Securities Group Inc. now owns 83,889 shares of the real estate investment trust's stock worth $1,547,000 after purchasing an additional 2,557 shares in the last quarter. Institutional investors own 99.40% of the company's stock.

Sabra Healthcare REIT Stock Performance

NASDAQ:SBRA opened at $20.61 on Monday. The company has a market cap of $5.27 billion, a price-to-earnings ratio of 79.27, a PEG ratio of 1.57 and a beta of 0.64. Sabra Healthcare REIT has a fifty-two week low of $17.17 and a fifty-two week high of $22.77. The company has a debt-to-equity ratio of 0.95, a quick ratio of 3.07 and a current ratio of 3.07. The stock has a fifty day moving average price of $20.43 and a 200-day moving average price of $20.16.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) EPS for the quarter, missing analysts' consensus estimates of $0.17 by ($0.27). The company had revenue of $230.11 million during the quarter, compared to the consensus estimate of $219.39 million. Sabra Healthcare REIT had a return on equity of 2.34% and a net margin of 7.61%.The firm's revenue for the quarter was up 24.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.38 EPS. As a group, equities analysts anticipate that Sabra Healthcare REIT will post 1.52 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, August 31st. Shareholders of record on Friday, August 14th will be given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 5.8%. The ex-dividend date is Friday, August 14th. Sabra Healthcare REIT's payout ratio is currently 461.54%.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc NASDAQ: SBRA is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra's tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source